Trial NCT02241551

View at ClinicalTrials.gov 
Org. Study IDs: UPCI 13-143

Last trial update was posted on 2018-07-26

MeSH Interventions

Fluorouracil Gemcitabine Irinotecan Oxaliplatin Paclitaxel

MeSH Conditions

Pancreatic Neoplasms

Other Conditions

Borderline Resectable Pancreatic Cancer

Stopping Reasons

Study was terminated with the IRB ended early as logistical concerns of the SBRT

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID